Neuropsychopharmacologia Hungarica最新文献

{"title":"Spiritual Health in Iranian University Students: a Systematic Review and meta-analysis.","authors":"Mohammad Tahan,&nbsp;Farank Azari","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Background and Aim: Spiritual health (SH), as the guiding force that maintains equilibrium in three dimensions of health - physical, mental, and social - can significantly contribute to the quality of life in humans. Therefore, the present study was to reflect on the levels of SH among Iranian university students. Materials and Methods: This study was fulfilled, employing a systematic review and meta-analysis, from November to December 2020. All the relevant articles, focusing on SH assessment in Iranian university students, published in seven valid databases between 2012 and 2020 were accordingly collected and evaluated. Finally, 20 articles were selected and analyzed using the Stata software. Results: A total of 20 studies conducted in Iran based on a sample size of 4805 individuals was found during the time period of 2012 and 2021. Spiritual Health in Iranian University Students was estimated to be 80.50 (95% CI, 73.56% - 87.44%). Conclusion: Considering the synthesis of the reviewed articles, SH was reported to be at high levels in nearly all Iranian university students, as expected in the Iranian-Islamic society. (Neuropsychopharmacol Hung 2022; 24(2): 78-84).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"24 2","pages":"78-84"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40526245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Poor Adherence to Oral Psychiatric Medication in Adults with Schizophrenia May Be Influenced by Pharmacophobia, High Internal Health Locus of Control and Treatment Duration.","authors":"Carlos De Las Cuevas,&nbsp;Trino Baptista,&nbsp;Mariano Motuca,&nbsp;G Alejandro Villasante-Tezanos,&nbsp;Judit Lazary,&nbsp;Laszlo Pogany,&nbsp;Jose De Leon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective: This study in Spain, Argentina, and Venezuela included 212 schizophrenia outpatients prescribed 387 psychiatric medications and 1,160 other psychiatric outpatients prescribed 2,067 medications. Methods: Logistic regression models included adherence for each psychiatric medication, measured by the Sidorkiewicz Adherence Tool, as the dependent variable. The models provided adjusted odds ratios (ORs) of dichotomous independent variables: 1) clinical variables, 2) subscales from the Patient Health Beliefs Questionnaire on Psychiatric Treatment (presence/absence of pharmacophobia and pharmacophilia and high/low psychological reactance, internal health locus of control [HLOC] and doctor's HLOC) and 3) presence/absence of skepticism toward each medication measured by the Beliefs about Medicines Questionnaire (BMQ). Results: ORs significant in both groups were: 1) pharmacophobia (OR=0.389 in schizophrenia, OR=0.591 in other patients and not significantly different) and 2) pharmacophilia (respectively OR=2.18, OR=1.59 and significantly higher in schizophrenia: p=0.012). Prescribing the medication for >1 year increased adherence in schizophrenia (OR=1.92) while decreasing it in others (OR=0.687). Four ORs were significant in the schizophrenia group but not in the controls: treatment for >1 year (OR=0.161), high internal LOC (OR=0.389), extreme polypharmacy (OR=1.92) and the country of Spain (OR=0.575). Regarding antipsychotics, the study included 204 schizophrenia patients prescribed 240 antipsychotic medications and 301 other patients prescribed 315 antipsychotic drugs. Three ORs were significant for antipsychotic adherence in the schizophrenia group: pharmacophobia (OR=0.324), treatment for >1 year (OR=0.362), and skepticism about specific antipsychotics (OR=0.535). Conclusions: Future adherence studies for antipsychotic/all medications should further explore the specificity/commonality of these dimensions in schizophrenia versus other psychiatric patients. (Neuropsychopharmacol Hung 2021; 23(4): 388-404).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 4","pages":"388-404"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39775403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.","authors":"Judit Lazary,&nbsp;Laszlo Pogany,&nbsp;Carlos De Las Cuevas,&nbsp;G Alejandro Villasante-Tezanos,&nbsp;Jose De Leon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Findings of three articles reporting results in 1372 stabilized outpatients taking 2454 medications in Spain, Argentina, and Venezuela were combined. Prevalence of good adherence was not obviously different across diagnoses: 69.5% (N=212) for schizophrenia, 66.3% (N=142) for bipolar disorder, and 69.8% (N=521) for depression. Besides the focus on stabilized outpatients, other study biases included use of a research sample; limited to oral medications, ignoring long-acting injectable antipsychotics; and lack of data on active substance abuse, clinical severity, and insight. Logistic regression models explored predictors of good vs. poor adherence. The six self-reported variables studied were pharmacophobia, pharmacophilia, high psychological reactance, high internal health locus of control (LOC), high doctor LOC, and skepticism concerning specific medications. ORs were significant in 56% (47/84) of the statistical tests vs. 24% (23/98) of ORs significant in case of 7 demographic/clinical variables (p=0.001). At least 2/3 of the ORs for pharmacophobia, pharmacophilia and skepticism were significantly associated with adherence in cases and controls, indicating their independence from diagnoses. In need of replication, three other self-reported measures had differential effects on adherence across diagnoses. High psychological reactance was associated with decreased adherence to antidepressant medications in general, or for patients with mood disorders. High internal LOC as associated with poor adherence may reflect the distrust patients with schizophrenia or severe bipolar disorder have of other people. High doctor LOC was significantly associated with increased adherence only in patients with bipolar disorder, but was significant for all medications, mood stabilizers and antipsychotics, indicating the relevance of the patient-psychiatrist relationship in these patients. (Neuropsychopharmacol Hung 2021; 23(4): 363-373).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 4","pages":"363-373"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39775401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Poor Adherence to Oral Psychiatric Medication in Adults with Depression: Psychological Reactance May Have Specific Effects in Depression.","authors":"Carlos De Las Cuevas,&nbsp;Mariano Motuca,&nbsp;Trino Baptista,&nbsp;G Alejandro Villasante-Tezanos,&nbsp;Judit Lazary,&nbsp;Laszlo Pogany,&nbsp;Jose De Leon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective: Medication adherence in psychiatric disorders, including depression, may be influenced by 6 self-reported dimensions: 1) high/low doctor health locus of control (HLOC), 2) high/low internal HLOC, 3) high/low psychological reactance, 4) pharmacophilia, 5) pharmacophobia, and 6) skepticism about a specific medication. This study in Spain, Argentina, and Venezuela included 521 outpatients with depression prescribed 920 psychiatric medications and 851 other psychiatric outpatients prescribed 1534 medications. Methods: Logistic regression models were completed in patients with depression and psychiatric controls. The dependent variable was adherence for each psychiatric medication (Sidorkiewicz Adherence Tool). The models provided adjusted odds ratios (ORs) of dichotomous independent variables: clinical variables, and 6 self-reported dimensions. Results: ORs significant in both diagnostic groups were: 1) pharmacophobia (OR=0.500 in depression, OR=0.599 in other patients), 2) pharmacophilia (respectively OR=1.51, OR=1.65), 3) treatment for 1 year (respectively OR=0.731, OR=0.608), 4) geriatric age (respectively OR=2.28, OR=3.02), and 5) skepticism about a specific medication (respectively OR=0.443, OR=0.569). Two ORs were significant in the depression group, but not in the controls: the country of Spain (OR=0.744), and high psychological reactance (OR=0.685). The study included 470 depression patients prescribed 510 antidepressants and 348 other patients prescribed 370 antidepressants. One OR was significant for antidepressant adherence in both groups: high psychological reactance (respectively OR=0.597, OR=0.561). Conclusions: All clinical studies using self-report include biases but the most important is lack of access to patients not coming for treatment. Future studies should further explore the specificity/commonality of these dimensions, particularly psychological reactance, in depression versus other psychiatric disorders. (Neuropsychopharmacol Hung 2021; 23(4): 374-387).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 4","pages":"374-387"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39775402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Practical Approach to Measuring and Predicting Medication Adherence by Outpatient's SelfReport After More than 10 Years of Research in Psychopharmacology.","authors":"Carlos De Las Cuevas,&nbsp;Judit Lazary,&nbsp;Laszlo Poganyi,&nbsp;Jose De Leon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Schizophrenia, bipolar disorder and major depression are associated with nonadherence registered mean figures of around 50%, highlighting the relevance of having simple adherence tools to incorporate into daily clinical practice. For 10 years we have focused on self-report as an assessment method and have studied thousands of outpatients taking thousands of psychiatric medications in three countries. Measurement of treatment adherence during use of polypharmacy is a really complex task as patients could adhere differently to the various medications prescribed, making it essential to assess adherence to each individual medication. This was not possible until the introduction of the Sidorkiewicz Adherence Tool that allows one to separate adherence to each medication, whether poor or not. Health psychologists have developed the Health Belief Model which has not received enough attention by psychiatrists. Based on this model, we have focused on personality styles and specific beliefs concerning specific medications as possible predictors of poor adherence. We developed the Patient Health Beliefs Questionnaire on Psychiatric Treatment which provides 5 self-reported personality dimensions: negative aspects of medication (pharmacophobia), positive aspects of medication (pharmacophilia), high/low psychological reactance, high/low doctor health locus of control (HLOC) and high/low internal HLOC. Based on the Beliefs about Medicines Questionnaire we have developed a measure of skepticism, defined as a patient's high concern about adverse reaction to an individual medication and a low belief in its necessity. Our research experience based on the tools for assessing and predicting adherence is presented in a practical manner by using seven boxes and examples. (Neuropsychopharmacol Hung 2021; 23(4): 336-346).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 4","pages":"336-346"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39864007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Poor Adherence to Oral Psychiatric Medication in Adults with Bipolar Disorder: The Psychiatrist May have More Influence than in Other Severe Mental Illnesses.","authors":"Carlos De Las Cuevas,&nbsp;G Alejandro Villasante-Tezanos,&nbsp;Mariano Motuca,&nbsp;Trino Baptista,&nbsp;Judit Lazary,&nbsp;Laszlo Pogany,&nbsp;Jose De Leon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective: Medication adherence in bipolar disorder (BD) may be influenced by 6 selfreported dimensions: 1) high/low psychological reactance, 2) high/low internal healthlocus of control (HLOC), 3) high/low doctor HLOC, 4) pharmacophobia, 5) pharmacophilia, and 6) skepticism about a specific medication. This study in Spain, Argentina, and Venezuela included 142 outpatients with BD prescribed 320 psychiatric medications and 1230 other psychiatric outpatients prescribed 2134 medications. Methods: Logistic regression models included adherence for each psychiatric medication, measured by the Sidorkiewicz Adherence Tool as the dependent variable. The models provided adjusted odds ratios (ORs) of dichotomous independent variables: clinical variables and 6 self-reported dimensions. Results: ORs significant in both groups were: 1) high doctor HLOC (OR=1.87 in BD, OR=1.25 in other patients), 2) high psychological reactance (respectively OR=0.572, OR=0.798), 3) pharmacophobia (respectively OR=0.361, OR=0.614), and 4) skepticism about a specific medication (respectively OR=0.300, OR=0.556). Two ORs were only significant in BD patients: medication duration > 1 year (OR=0.449), and extreme polypharmacy (OR=2.49). The study included 104 BD patients prescribed 122 mood stabilizers and 136 other patients prescribed 140 mood stabilizers. Two ORs were significant for mood stabilizer adherence only in BD patients: high doctor HLOC and skepticism (respective ORs=2.38, OR=0.390). The study included 87 BD patients prescribed 97 antipsychotics and 417 other patients prescribed 458 antipsychotics. Four ORs were significant for antipsychotic adherence only in the BD group. Conclusions: Future studies of adherence to all/specific medications should explore the specific city/commonality of these dimensions, particularly doctor HLOC, in BD versus other psychiatric patients. (Neuropsychopharmacol Hung 2021; 23(4): 347-362).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 4","pages":"347-362"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39636640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The relationship between schizotypy, empathy and mentalization based on the research of the last decade.","authors":"Edina Torok,&nbsp;Szabolcs Keri","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Research on schizotypy dates back to the 1960s, and their association with mentalization also dates back at least 15 years. However, unfortunately, the results are mainly contradictory. This review aims to clarify why the results are so different and fi nd a correlation between the tests and the results. Publications for the review were selected from PubMed by searching for the following keywords: \"schizotypy + theory of mind, mentalization, empathy\". We also used the reference lists of published reports for additional studies. Criteria for the studies were: investigated the relationship between schizotypy and mentalization or schizotypy and empathy in a non-clinical sample. We grouped the results according to correlations, tests, theory of mind, and mentalization. Studies with relatives of schizophrenic patients were excluded from the research. The comparison included 39 articles covering a total of 42 studies. The total number of participants was 10139, with an average age of 20.4 years. Schizotypy was measured with eight different tests, mentalization was measured with 12 tests, and empathy was measured with two types of tests. Studies have found an association between schizotypal traits and mentalization or schizotypal traits and empathy in 28 cases. Research that found a correlation between mentalization and schizotypy used different tests to measure mentalization. Overall, the inconsistent results are due to the diversity of mentalization and the multidimensional characteristic of the schizotypy.</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 3","pages":"288-295"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39691151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interaction between emotional context-guided shifting and cognitive shifting: Introduction of a novel task.","authors":"Brigitte Biro,&nbsp;Gyongyi Kokonyei,&nbsp;Raissa De Oliveira Negrao,&nbsp;Adel Dancsik,&nbsp;Szilvia Karsai,&nbsp;H N Alexander Logemann,&nbsp;Renata Cserjes","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Aim: Task shifting is considered as a critical component of cognitive flexibility that underlies the ability to flexibly switch between tasks. It is measured by performance-based tasks, where participants have to select/ignore simple target stimuli such as letters, numbers, or words according to certain rules. However, in everyday life individuals need to manage and shift between more complex, often emotionally charged stimuli. Previous paradigms developed to measure affective flexibility are based on the task where the focus is to shift between emotional and non-emotional stimuli, instead of the flexible shift between emotional valences. In view of this, the aim of the present study was to develop the Emotional Shifting Task, a novel paradigm that is created with the purpose of assessing emotional flexibility abilities by means of a novel valence-specific shifting design. Furthermore, scientific discussion regarding the relationship between cognitive and emotional flexibility abilities, a connection that is rarely addressed in the literature would be addressed. Method: In the present paper, task shifting was assessed by means of the Task Switching Task while the Emotional Shifting Task method evaluated emotional flexibility abilities in an online setting. Results: The results revealed a significant, positive relationship between task shifting and emotional shifting from positive to negative images only. Furthermore, when fast and slow performers on TST were distinguished results showed that fast performers on TST were also faster on EST shift conditions in general, but not on EST non-shift condition. Conclusion: These findings indicate that cognitive and emotional flexibility abilities may be interrelated. Our results seem to indicate a connection between the two shifting abilities. (Neuropsychopharmacol Hung 2021; 23(2): 319-330).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 3","pages":"319-330"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39691154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can you get off the rollercoaster? Psychotherapeutic interventions in bipolar disorder.","authors":"Berta Erdelyi-Hamza,&nbsp;Livia Elek,&nbsp;Xenia Gonda","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bipolar affective disorder is a chronic illness that usually causes significant psychosocial deficits and functional impairment and is also associated with excess mortality. It is underlied by an endogenous pathology with pharmacotherapy as primary treatment. However, in many cases, medication treatment alone is associated with limited adherence, low remission rates, increased potential for relapse and residual symptoms, which is why bipolarity-specific psychotherapeutic interventions are increasingly gaining ground as an integral part of the management of the disease. An increasing amount of research and evidence suggest that complementary psychotherapeutic interventions improve patients' long-term functioning, and argue for the involvement of psychologists and other helping professionals in the long-term care of patients with bipolar disorder. In this article we overview the major therapeutic methods specifically targeted at this group of patients, including individual and group psychoeducation, cognitive behavioural therapy, family therapy, Interpersonal and Social Rhythm Therapy (IPSRT), Integrated Care Management, Think Effectively About Mood Swings (TEAMS), Imagery Based Emotion Regulation (IBER), and other individual and group techniques and psychotherapeutic interventions, also mentioning efficacy studies and effects experienced by patients.</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 3","pages":"296-307"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39691152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What is the dominant treatment attitude of psychiatric patients?","authors":"Laszlo Pogany,&nbsp;Carlos De las Cuevas,&nbsp;Judit Lazary","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Background: Patients' attitude towards drug treatment is of prognostic value regarding adherence. However, few detailed analyses have been performed regarding the influencing factors of the treatment attitude of psychiatric patients. Methods: We enrolled in the study 295 psychiatric inpatients and analyzed the data obtained using the recently developed Patient's Health Belief Questionnaire on Psychiatric Treatment (PHBQPT), the Behavioural Inhibition/ Activation System (BIS/BAS) Scale, and the Hospital Anxiety and Depression Scale. We created a 'dominant treatment attitude' (DTA) variable from the 5 subscales of the PHBQPT. Results: The most common DTA was the Doctor HLOC and the rarest proved to be the Psychological Reactance. The double DTA carriers were the most frequently occurring multiple DTAs. We found that the Doctor-HLOC coupled most frequently with the Positive Aspect and the DoctorHLOC with the Internal-HLOC. The Doctor-HLOC score was higher while the BAS Fun seeking score lower in the case of patients treated for affective disorders compared to patients who belonged to the psychosis and personality disorder subgroups. Conclusions: Screening of DTAs in psychiatric patients can provide useful information for the planning of a more effective therapeutic strategy. (Neuropsychopharmacol Hung 2021; 23(2): 308-318).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 3","pages":"308-318"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39602317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}